Stockreport

BioMarin Acquiring Amicus -- Both Great Companies, Only One Worth Buying Now [Seeking Alpha]

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
PDF In fact, Amicus could potentially double its reach, going from 40 to 80 countries. I'm downgrading BMRN from Strong Buy to Buy. Voxzogo is decelerating from 20% to 15% [Read more]